Article Details

Inflammatix Announces Appointment of Oliver Liesenfeld, MD, as Chief Medical Officer

Retrieved on: 2017-12-18 21:07:13

Tags for this article:

Click the tags to see associated articles and topics

Inflammatix Announces Appointment of Oliver Liesenfeld, MD, as Chief Medical Officer. View article details on hiswai:

Excerpt

<div>The privately held, Burlingame, Calif.-based company is funded by <b>Khosla</b> <b>Ventures</b>, Stanford-StartX Fund and the U.S. government's Defense Advanced Research Projects Agency (DARPA). For more information, please visit www.inflammatix.com and follow the company on Twitter (@Inflammatix_Inc).</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo